Pitt-Hopkins syndrome

Pitt-Hopkins syndrome (PTHS) is a neurodevelopmental condition caused by a pathogenic change that reduces TCF4 function. Development, movement, communication, breathing regulation, vision, sleep, seizures, feeding, and gastrointestinal health may be affected. The pattern and support needs vary substantially.1

Urgent safety

Call emergency services for sustained apnea, blue or gray color, collapse, severe breathing effort, reduced responsiveness, or a breathing event that does not recover as expected under the person's plan. Do not assume every pause, color change, or collapse is a routine Pitt-Hopkins breathing episode. A first, prolonged, substantially changed, sleep-related, or injurious event needs clinical assessment.1

Follow the person's seizure action plan. Emergency assessment is appropriate for a first seizure, a seizure that reaches the plan's emergency threshold, repeated seizures without recovery, breathing difficulty, or serious injury. Severe abdominal pain or distension with bilious vomiting can indicate bowel obstruction and is also an emergency.1

Clinical pattern and diagnosis

Possible features include:

• developmental and learning differences, with expressive speech often more affected than understanding;
• hypotonia, delayed motor skills, an unsteady gait, or later mobility limitations;
• episodic hyperventilation, breath-holding, or apnea while awake;
• seizures, sleep disturbance, constipation, reflux, feeding difficulty, or aspiration risk;
• myopia, astigmatism, strabismus, or cerebral visual impairment;
• scoliosis, foot differences, reduced sweating, heat intolerance, or altered pain responses.

The characteristic breathing pattern may start later or may not occur. Typical autonomic episodes are mainly awake; symptoms during sleep need assessment for obstructive apnea, hypoxemia, hypoventilation, or another cause. Apparent high pain tolerance does not rule out illness or injury.1

Diagnosis requires suggestive clinical findings plus a heterozygous pathogenic or likely pathogenic TCF4 variant, an intragenic deletion, or a chromosome 18q21.2 deletion involving TCF4. A TCF4 variant of uncertain significance does not confirm or exclude PTHS. Genetic counseling should address the tested mechanism and family-specific recurrence questions.1

Treatment and follow-up

There is no curative treatment. Care is directed to the person's breathing, seizures, sleep, constipation and reflux, feeding, vision, movement, orthopedic health, communication, learning, comfort, and participation. Respiratory medicine should assess recurrent or concerning breathing episodes, chronic hypoxemia, or possible sleep-disordered breathing. Medication for respiratory dysregulation is specialist-led and requires monitoring.1

Sudden distress, withdrawal, sleep change, or reduced participation should prompt assessment for pain, constipation, reflux, infection, seizure change, medication effects, sensory overload, or communication barriers rather than being attributed automatically to behavior.

Feeding and communication

Swallowing review should consider coughing or choking, respiratory symptoms, prolonged meals, growth and hydration, reflux, positioning, drooling, and oral-motor function. Texture, pacing, posture, equipment, exercises, and tube feeding require direct assessment.1

Speech output can markedly underrepresent comprehension, preference, and intent. Offer a communication system early and presume the person has something to say. Use body movement, facial expression, vocalization, gesture, sign, objects, photos or symbols, partner-assisted scanning, and speech-generating AAC as useful to the person. Include real choices, consent and refusal, social language, learning vocabulary, and urgent messages.

Do not prescribe eye gaze, touch, switches, or a symbol level from the diagnosis. Trial access while accounting for fine-motor control, vision, attention, positioning, fatigue, breathing episodes, and seizure state. Train partners, allow processing time, and keep a low-tech backup.1 For evaluation, trials, funding, and implementation, use the AAC device acquisition guide.

Coding

The current US ICD-10-CM set does not provide a Pitt-Hopkins-specific descriptor. Coding should reflect the documented molecular diagnosis and associated conditions under current local rules; confirm selection with a qualified coder rather than copying a nonspecific syndrome code.4

Sources

1. Sweetser et al. Pitt-Hopkins Syndrome, GeneReviews — current diagnosis, genetics, breathing, gastrointestinal, sleep, vision, communication, and management guidance (updated 2025).
2. Zollino et al. Diagnosis and management in Pitt-Hopkins syndrome: international consensus statement — condition-specific diagnostic and care consensus.
3. American Speech-Language-Hearing Association: Augmentative and Alternative Communication — individualized, multimodal AAC assessment without prerequisites.
4. Centers for Medicare & Medicaid Services: FY2026 ICD-10-CM definitions — current congenital and gene-related neurodevelopmental descriptors.

Review boundary

This page cannot diagnose Pitt-Hopkins syndrome, interpret genetic results, or remotely assess breathing, seizure, bowel, swallowing, pain, or communication safety. Emergencies need immediate local assessment. Medication, diet, equipment, and communication decisions need direct review with qualified clinicians and the person.